Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 178

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 178
---
. Synthesis can occur both naturally and in the laboratory.                 |
| Synthetic           |     | A                                                                                                                                       
 chemical or compound that is produced artificially in a laboratory rather than a natural system. Naturally occurring molecules can      
 be made synthetically, and have the same molecular structure and properties as the nature-made material.                                |
| TCPP                |     | A                                                                                                                                       
 specific synthetic (i.e., man-made) porphyrin molecule whose chemical name is meso-tetra (4-carboxyphenyl)                              
 porphine.                                                                                                                               |
| Transfection        |     | A                                                                                                                                       
 laboratory technique that is used to insert foreign nucleic acid (DNA or RNA) into a cell, typically with the intention of producing    
 a specific protein within the cell.                                                                                                     |
| Vitamin             
 B12                 |     | An                                                                                                                                      
 essential dietary nutrient that the body needs daily in small amounts to function and stay healthy. Vitamin B12 helps make red blood    
 cells, DNA, RNA, energy, and tissues, and keeps nerve cells healthy. It is found in liver, meat, eggs, poultry, shellfish, milk,        
 and milk products. Chronic lack of vitamin B12 can result in anemia and central nervous system problems.                                |

| 86 |

<div align='center'>bioAffinity Technologies, Inc.

Index to the Consolidated Financial Statements</div>

| Report of Independent Registered Public Accounting Firm (PCAOB ID NO. 100)                                                                
 Consolidated Balance Sheets as of December 31, 2024 and 2023                                                                              
 Consolidated Statements of Operations for the years ended December 31, 2024 and 2023                                                      | F-2 
 F-3 
 F-4 |
|:------------------------------------------------------------------------------------------------------------------------------------------|:----|
| Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Equity for the years ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023                                                      | F-6 |
| Notes to Consolidated Financial Statements                                                                                                | F-7 |

| F-1 |

<div align='center'>Report of Independent Registered Public Accounting Firm</div>

To the Board of Directors and Stockholders of

bioAffinity Technologies, Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of bioAffinity Technologies, Inc. (the “